Alexandra Smith

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

Peter Hillmen, D. Cohen, Kim Cocks et al. · British Journal of Haematology · 2011 · 41 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

Dena Howard, Talha Munir, Lucy McParland et al. · Leukemia · 2017 · 34 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +2

High Relapse Rates Despite Early Intervention with Intravenous Methylprednisolone Pulse Therapy for Severe Childhood Alopecia Areata

Alexandra Smith, Ralph M. Trüeb, Martin Theiler et al. · Pediatric Dermatology · 2015 · 31 citations

Medicine, Dermatology, Pediatrics +11

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

Oliver Coen, Pippa Corrie, Helen Marshall et al. · BMC Cancer · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Are we over-treating with checkpoint inhibitors?

Sarah Danson, Jane Hook, Helen Marshall et al. · British Journal of Cancer · 2019 · 22 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17